Assembly Biosciences (ASMB) Current Assets: 2015-2025
Historic Current Assets for Assembly Biosciences (ASMB) over the last 11 years, with Sep 2025 value amounting to $236.8 million.
- Assembly Biosciences' Current Assets rose 141.12% to $236.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $236.8 million, marking a year-over-year increase of 141.12%. This contributed to the annual value of $115.5 million for FY2024, which is 13.67% down from last year.
- As of Q3 2025, Assembly Biosciences' Current Assets stood at $236.8 million, which was up 205.69% from $77.5 million recorded in Q2 2025.
- In the past 5 years, Assembly Biosciences' Current Assets ranged from a high of $236.8 million in Q3 2025 and a low of $49.7 million during Q3 2023.
- Its 3-year average for Current Assets is $107.4 million, with a median of $98.2 million in 2024.
- In the last 5 years, Assembly Biosciences' Current Assets crashed by 56.84% in 2023 and then soared by 141.12% in 2025.
- Assembly Biosciences' Current Assets (Quarterly) stood at $154.2 million in 2021, then crashed by 37.12% to $97.0 million in 2022, then spiked by 37.97% to $133.8 million in 2023, then declined by 13.67% to $115.5 million in 2024, then spiked by 141.12% to $236.8 million in 2025.
- Its Current Assets was $236.8 million in Q3 2025, compared to $77.5 million in Q2 2025 and $95.5 million in Q1 2025.